Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies7,641–7,660 of 20,710
All studies
Impact of metformin in cardiometabolic risk factors in polycystic ovary syndrome: role of race/ethnicity
EFFECT OF BODY MASS INDEX ON PREGNANCY OUTCOMES IN POLYCYSTIC OVARY SYNDROME WOMEN UNDERGOING LETROZOLE-INTRAUTERINE INSEMINATION CYCLES
Metformin, Spironolactone and Oral Contraceptives Alone or in Combination in Polycystic Ovary Syndrome: A Network Meta-Analysis of Randomized Clinical Trials
To study on nutritional status in suffering from polycystic ovary syndrome (PCOS)
Kisspeptin Levels in Different Polycystic Ovary Syndrome (PCOS) Phenotypes
Association of Circulating Spexin Levels with Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Women and Normal Controls
Interplay of Low Serum Irisin Level and Insulin Resistance in Obese Polycystic Ovary Syndrome Patients: Potential Biomarker for Pre-clinical Risk Assessment and therapeutic intervention
Evaluation the Sensitivity and Specificity of Fucose and Some Biochemical Parameters as an Indicator of Therapeutic Response to Metformin in Polycystic Ovary Syndrome
Need to redefine letrozole resistance in polycystic ovary syndrome: understanding the concept of follicle-stimulating hormone threshold and window
Inadvertent surgical bleeding in PCOS patient with splenomegaly and its association with Non Alcoholic Fatty Liver Disease (NAFLD)
eLife assessment: Type I fiber decrease and ectopic fat accumulation in skeletal muscle from women with PCOS
Retraction notice to ”Laparoscopic ovarian drilling in polycystic ovary syndrome: efficacy of adjusted thermal dose based on ovarian volume”
What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II.
Inositol and herbal substances as elements of complementary therapy in patients with PCOS
Low-dose pioglitazone for polycystic ovary syndrome in adolescent girls: differential fat-mass redistribution by HOTAIR rs1443512 genotype
DOES OBESITY DRIVE THE DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME? AN EPIDEMIOLOGIC STUDY (SUPPLEMENTARY TABLES)
Distribution of FSHR-29 polymorphism among women with polycystic ovary syndrome and association with level of its receptor expression in Granulosa cells of infertile women
Influence of oral hormonal contraception on the concentration of anti-Müllerian and reproductive hormones in patients with polycystic ovary syndrome
TESTOSTERONE INDUCES CARDIAC REMODELLING AND CARDIAC DYSFUNCTION, AND ALTERS FATTY ACID METABOLISM IN A RODENT MODEL OF POLYCYSTIC OVARY SYNDROME
#48 : Blastocyst Versus Day-3 Embryo Transfers After In Vitro Maturation with Pre-Maturation Step (CAPA-IVM) in PCOS Patients